Adrenomedullin is a therapeutic target in colorectal cancer
Daniel C. Chung(Massachusetts General Hospital), Masayoshi Yamamoto(Harvard University), Senji Shirasawa(Harvard University), Thomas R. Austin(Harvard University), Daniel Shue(Brigham and Women's Hospital), Hirotoshi Kikuchi(Massachusetts General Hospital), Maria Simona Pino(Massachusetts General Hospital), Manish Gala(Harvard University), Bo R. Rueda(Harvard University), Lawrence Zukerberg(Harvard University), Maureen P. Lynch(Harvard University)
Cited by 28
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
The Chromosomal Instability Pathway in Colon Cancer
|Gastroenterology|2010|932